Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice

Endocrinology

Volumn 154, Issue 9, 2013, Pages 3366-3376

  Kim, H W ^a   Lee, J E ^a   Cha, J J ^b   Hyun, Y Y ^c   Kim, J E ^b   Lee, M H ^b   Song, H K ^b   Nam, D H ^b   Han, J Y ^d   Han, S Y ^e   Han, K H ^e   Kang, Y S ^b   Cha, D R ^b  

^a Wonkwang University   (South Korea)

^b Korea University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Inha University Hospital   (South Korea)

^e Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPOCYTOKINE; ADIPONECTIN; ALBUMIN; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR; GLUCOSE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; LIPID METABOLISM; LIPID PEROXIDATION; MALE; MESANGIUM CELL; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; URINARY EXCRETION; WESTERN BLOTTING;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; KIDNEY; LIPID PEROXIDATION; MALE; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OXIDATIVE STRESS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEINS;

EID: 84883151328     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2276     Document Type: Article

References (31)

1. Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet. 2004;20:563-569.
2. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627-1635.
3. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5:426-437.
4. Cancilla B, Ford-Perriss MD, Bertram JF. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney. Kidney Int. 1999;56:2025-2039.
5. Cancilla B, Davies A, Cauchi JA, Risbridger GP, Bertram JF. Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney Int. 2001;60:147-155.
6. Hale C, Chen MM, Stanislaus S, et al. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology. 2012;153:69-80.
7. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
8. Kang YS, Lee MH, Song HK, et al. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int. 2010;78:883-894.
9. Han SY, Kim CH, Kim HS, et al. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol. 2006;17:1362-1372.
10. HajerGR,van HaeftenTW,Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29: 2959-2971.
11. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705-712.
12. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 1997;36:1-21.
13. Betteridge DJ. What is oxidative stress? Metabolism. 2000;49:3-8.
14. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24-30.
15. Wang Z, Jiang T, Li J, et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes. 2005;54:2328-2335.
16. Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57:1246-1253.
17. Fisher FM, Chui PC, Antonellis PJ, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes. 2010;59:2781-2789.
18. Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens. 2008; 17:450-456.
19. Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149:6018-6027.
20. Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58:250-259.
21. Do HT, Tselykh TV, Makela J, et al. Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap). J Biol Chem. 2012;287:12602-12611.
22. Chartoumpekis DV, Ziros PG, Psyrogiannis AI, et al. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes. 2011;60:2465-2473.
23. Gaemers IC, Stallen JM, Kunne C, Wallner C, Werven JV, Nederveen A, Lamers WH. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. Biochim Biophys Acta. 2011;1812:447-458.
24. Schaap FG, Kremer AE, Lamers WH, Jansen PLM, Gaemers IC. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie. 2013;95:692-699.
25. Sakai N, Wada T, Furuichi K, et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis. 2005;45:54-65.
26. Lin CL, Wang FS, Kuo YR, et al. Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. Kidney Int. 2006;69:1593-1600.
27. Kunduzova OR, Bianchi P, Pizzinat N, et al. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J. 2002; 16:1129-1131.
28. Crasto C, Semba RD, Sun K, Ferrucci L. Serum fibroblast growth factor 21 is associated with renal function and chronic kidney disease in community-dwelling adults. JAmGeriatr Soc. 2012;60:792-793.
29. Han SH, Choi SH, Cho BJ, et al. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metabolism. 2010;59:1656-1662.
30. Loeffler I, Hopfer U, Koczan D, Wolf G. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. J Am Soc Nephrol. 2011;22:649-663.
31. Wolf G, Schanze A, Stahl RAK, Shankland SJ, Amann K. p27Kip1 knockout mice are protected from diabetic nephropathy: evidence for p27Kip1 haplotype insufficiency. Kidney Int. 2005;68:1583-1589.